19
Aug 2026
Semaglutide trial targets people with liver disease, obesity and alcohol addiction
A new study -- co-led by the University of Plymouth, University Hospitals Plymouth NHS Trust, and the NIHR Biomedical Research Centre: Nottingham -- is being launched into a treatment for people impacted by liver disease, obesity and alcohol addiction.